This document summarizes a study on the use of the antibiotic isoniazid (brand name Hydrazid) to treat tuberculosis (TB). The study looked at adverse effects in the first 100 patients prescribed isoniazid. 56 patients reported at least one adverse effect, with 6 experiencing severe adverse effects. Increased age was found to significantly increase the risk of adverse effects. 85% of patients completed the isoniazid therapy, while 10% stopped due to adverse effects. Isoniazid is recommended for treating TB where the organisms are susceptible and is a first-line medication for preventing and treating TB.
This document summarizes a study on the use of the antibiotic isoniazid (brand name Hydrazid) to treat tuberculosis (TB). The study looked at adverse effects in the first 100 patients prescribed isoniazid. 56 patients reported at least one adverse effect, with 6 experiencing severe adverse effects. Increased age was found to significantly increase the risk of adverse effects. 85% of patients completed the isoniazid therapy, while 10% stopped due to adverse effects. Isoniazid is recommended for treating TB where the organisms are susceptible and is a first-line medication for preventing and treating TB.
This document summarizes a study on the use of the antibiotic isoniazid (brand name Hydrazid) to treat tuberculosis (TB). The study looked at adverse effects in the first 100 patients prescribed isoniazid. 56 patients reported at least one adverse effect, with 6 experiencing severe adverse effects. Increased age was found to significantly increase the risk of adverse effects. 85% of patients completed the isoniazid therapy, while 10% stopped due to adverse effects. Isoniazid is recommended for treating TB where the organisms are susceptible and is a first-line medication for preventing and treating TB.
Name:Rayhan Ahmed Roll No: 1409 Course: Pharmaceutical Marketing ISONIAZID (BRAND NAME : HYDRAZID) MEDICAL TREATMENT PROBLEM:
Isoniazid is an antibiotic that fights bacteria
. Isoniazid is used to treat and to prevent tub erculosis (TB). You may need to take other TB m edicines in combination with isoniazid. When tr eating active TB, isoniazid must be used with o ther TB medicines. It may also be used for atyp ical types of mycobacteria.Tuberculosis may be resistant to isoniazid if used alone. METHOD: All patients commencing treatment for LTBI pr ospectively were enrolled in an ongoing datab ase of LTBI treatment outcomes particularly r elated to adverse effects,treatment adherenc, and treatment cocompletion.
Every breath counts -- Stop TB now
RESULTS: Data on the first 100 patients who were presc ribed isoniazid are presented.56 patients rep orted at least one adverse effect at some sta ge during treatment,with 6 experiencing at le ast one WHO Grade 3--4 adverse effect.IIncrea sed age was significantly associated with ris k of adverse effects(odds ratio)OR=1.05 per y ear and (confidence interval)CI=1.02-1.08 95% . 85% had documented completion of therapy lo cally with10% ceasing IPT due to adverse effe ct. INDICATION: Recommended for all forms of tuberculosis in which organisms are susceptible. SELLING POINTS:
• First - line medication in the prevention and
treatment of Tuberculosis. • Available in tablet,syrup,iinjectable forms. • Good bioavailability.